ArticleJBMR plus2026

Repeated romosozumab with short-term ibandronate sequencing in high-risk osteoporosis: a retrospective single-center cohort study.

Hiroyuki Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.